Stergios Moschos
Hematology & Oncology · Unc Physicians and Associates
Credentials: · · ·
History
National & Kapodistrian University of Athens
Research
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
New England Journal of Medicine · 2012 · 1,763 citations
The Lancet Oncology · 2015 · 1,307 citations
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
New England Journal of Medicine · 2018 · 1,083 citations
33 papers
16 papers
- AT
14 papers
14 papers
10 papers
10 papers · 1 as a fellow
10 papers
9 papers
Grants
- 2018–2024
Development of IDO PET Agents for Immunotherapy
National Cancer Institute · R01
PI · $2M · Univ of North Carolina Chapel Hill
Clinical trials
- 2026–2029
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Principal investigator · Not yet recruiting · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2019–2023
An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2018–2023
Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
- 2018–2028
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Principal investigator · Recruiting · Phase 1
UNC Lineberger Comprehensive Cancer Center